Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$PBYI Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.16 up 33.33% YoY
• Reported revenue of $56.5M up 7.75% YoY
• Puma Biotechnology raised its full year 2026 guidance, now anticipating net product revenue of $205-$209 million, total revenue of $224-$231 million, and net income in the range of $17-$20 million.Price since post
Advertisement|Remove ads.